96 related articles for article (PubMed ID: 9042318)
1. Prognostic value of nuclear grading assessed by image cytometry for node negative breast cancer patients.
Kimijima I; Watanabe T; Abe R
Anticancer Res; 1996; 16(6C):3949-53. PubMed ID: 9042318
[TBL] [Abstract][Full Text] [Related]
2. Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer.
Mariuzzi L; Mombello A; Rucco V; Morelli L; Zamò A; Thompson D; Vaught L; Bartels HG; Mariuzzi G; Bartels PH
Adv Clin Path; 2000 Apr; 4(2):87-97. PubMed ID: 11080789
[TBL] [Abstract][Full Text] [Related]
3. Nuclear cytometric changes in breast carcinogenesis.
Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
[TBL] [Abstract][Full Text] [Related]
4. Nuclear morphometry in prognostication of breast cancer in Saudi Arabian patients: comparison with European and African breast cancer.
Buhmeida A; Al-Maghrabi J; Merdad A; Al-Thubaity F; Chaudhary A; Gari M; Abuzenadah A; Collan Y; Syrjänen K; Al-Qahtani M
Anticancer Res; 2010 Jun; 30(6):2185-91. PubMed ID: 20651368
[TBL] [Abstract][Full Text] [Related]
5. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
Masiuk M
Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients.
Kurosumi M; Tabei T; Inoue K; Takei H; Ninomiya J; Naganuma R; Suemasu K; Higashi Y; Tsuchiya E
Oncol Rep; 2003; 10(4):833-7. PubMed ID: 12792731
[TBL] [Abstract][Full Text] [Related]
7. [Some morphometric parameters of nucleoli and nuclei in invasive ductal breast carcinomas in women].
Karpinska-Kaczmarczyk K
Ann Acad Med Stetin; 2009; 55(1):90-6. PubMed ID: 20349598
[TBL] [Abstract][Full Text] [Related]
8. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
9. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.
Abdalla F; Boder J; Markus R; Hashmi H; Buhmeida A; Collan Y
Anticancer Res; 2009 May; 29(5):1771-6. PubMed ID: 19443402
[TBL] [Abstract][Full Text] [Related]
10. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
[TBL] [Abstract][Full Text] [Related]
11. Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.
Giardina C; Serio G; Lepore G; Lettini T; Dalena AM; Pennella A; D'Eredità G; Valente T; Ricco R
J Exp Clin Cancer Res; 2003 Jun; 22(2):279-88. PubMed ID: 12866579
[TBL] [Abstract][Full Text] [Related]
12. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
13. Quantitative study of ductal breast cancer progression: nuclear signatures for evaluation of progression grade.
Mombello A; Mariuzzi L; Morelli L; Granchelli G; Rucco V; Tarocco E; da Silva VD; Thompson D; Bartels HG; Bartels PH; Mariuzzi G
Adv Clin Path; 2001 Jul; 5(3):59-70. PubMed ID: 11753877
[TBL] [Abstract][Full Text] [Related]
14. Use of nuclear image cytometry, histopathological grading and DNA cytometry to make breast cancer prognosis more objective.
Theissig F; Dimmer V; Haroske G; Kunze KD; Meyer W
Anal Cell Pathol; 1991 Nov; 3(6):351-60. PubMed ID: 1751402
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of necrosis in Nigerian breast cancer.
Ikpatt O; Ndoma-Egba R; Collan Y
Adv Clin Path; 2002 Jan; 6(1):31-7. PubMed ID: 17582946
[TBL] [Abstract][Full Text] [Related]
16. Nuclear profiles of cancer cells reveal the metastatic potential of gastric cancer.
Ikeguchi M; Cai J; Oka S; Gomyou Y; Tsujitani S; Maeta M; Kaibara N
J Pathol; 2000 Sep; 192(1):19-25. PubMed ID: 10951395
[TBL] [Abstract][Full Text] [Related]
17. Computer-generated nuclear features compared with axillary lymph node status and tumor size as indicators of breast cancer survival.
Wolberg WH; Street WN
Hum Pathol; 2002 Nov; 33(11):1086-91. PubMed ID: 12454812
[TBL] [Abstract][Full Text] [Related]
18. Grading and prognosis of invasive ductal mammary carcinoma by nuclear image analysis in tissue sections.
Kunze KD; Haroske G; Dimmer V; Meyer W; Theissig F
Pathol Res Pract; 1989 Nov; 185(5):689-93. PubMed ID: 2560542
[TBL] [Abstract][Full Text] [Related]
19. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C
Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of radically operated breast carcinoma patients. A retrospective study of 167 consecutive patients with emphasis on histopathological grading, reproducibility and mean nuclear area.
Raabe NK; Schistad O; Sauer T; Bofin A; Kaaresen R; Fossaa SD
APMIS; 1997 May; 105(5):363-70. PubMed ID: 9201237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
